Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

BC024139 Inhibitors

The chemical class of "BC024139 Inhibitors" encompasses a diverse range of compounds known for their ability to indirectly modulate the activity of the protein encoded by the BC024139 gene. This modulation is achieved through the influence exerted on various signaling pathways and cellular processes that intersect with the protein's functionality. The uniqueness of this class lies in its indirect approach to influencing protein activity, emphasizing the intricate network of cellular signaling rather than direct interaction with the target protein.

The class includes molecules like Cyclic ADP-Ribose (cADPR) and Inositol 1,4,5-triphosphate (IP3), which are instrumental in calcium signaling. cADPR, a calcium-mobilizing nucleotide, and IP3, a well-known secondary messenger, regulate intracellular calcium levels, thus potentially affecting BC024139 activity through calcium-dependent signaling mechanisms. This highlights the importance of calcium ions as universal signaling entities in cellular processes, capable of influencing a wide array of proteins, including BC024139. Similarly, Dibutyryl cAMP (db-cAMP), a cAMP analog, mimics the action of cAMP, a key secondary messenger in cells, and can potentially affect BC024139 activity through cAMP-dependent signaling pathways, illustrating the complex interplay between different signaling molecules.

Compounds like Thapsigargin and Ryanodine, which manipulate calcium homeostasis and release, respectively, further demonstrate the significance of calcium dynamics in protein regulation. Thapsigargin, by inhibiting the SERCA pump, increases cytosolic calcium levels, while Ryanodine affects calcium release from the sarcoplasmic reticulum, both potentially influencing BC024139 activity. This underscores the intricate control mechanisms governing intracellular ion concentrations and their impact on protein function.

Additionally, the class includes molecules like Wortmannin and U73122, which affect phosphoinositide and phospholipase C signaling pathways, respectively. These compounds reveal the multifaceted nature of protein regulation via various signaling pathways, where alterations in enzyme activities and secondary messengers can indirectly modulate protein function.

The "BC024139 Inhibitors" class represents an advanced understanding of cellular signaling and protein regulation. It illustrates the potential of targeting the broader network of signaling pathways to influence specific protein functions, rather than direct inhibition. This approach highlights the interconnectedness of cellular processes and the complexity of modulating protein activity within these networks. As research in this area progresses, it is expected to provide deeper insights into the regulation of proteins like BC024139 and expand the possibilities for biochemical and cellular research, further elucidating the intricate tapestry of cellular signaling and its impact on protein function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

db-cAMP, a cAMP analog, can mimic the action of cAMP in cells, potentially affecting BC024139 activity through cAMP-dependent signaling pathways.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin, a SERCA pump inhibitor, can increase cytosolic calcium levels, potentially influencing BC024139 activity by altering calcium homeostasis.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Okadaic Acid, a potent inhibitor of protein phosphatases 1 and 2A, can alter protein phosphorylation states, potentially affecting BC024139 activity.

Ryanodine

15662-33-6sc-201523
sc-201523A
1 mg
5 mg
$223.00
$799.00
19
(2)

Ryanodine, by modulating the activity of ryanodine receptors, can influence calcium release from the sarcoplasmic reticulum, potentially affecting BC024139 activity.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

Nifedipine, a calcium channel blocker, can influence calcium influx, potentially affecting BC024139 activity through the modulation of calcium signaling.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

BAPTA-AM, a calcium chelator, can modulate intracellular calcium levels, potentially influencing BC024139 activity by affecting calcium-dependent pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, an inhibitor of phosphoinositide 3-kinases, can affect multiple signaling pathways, potentially influencing BC024139 activity through PI3K/Akt signaling modulation.

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$28.00
$53.00
37
(1)

2-APB, a modulator of IP3 receptors and store-operated calcium channels, can affect calcium signaling, potentially influencing BC024139 activity.